TNKS2
Summary:
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
Nametankyrase 2 OMIM IDMIM:607128 Ensembl IDEnsembl:ENSG00000107854 HGNC IDHGNC:HGNC:15677 PHARMGKB IDPA38019 Map Location10q23.32 |
Gene Categories:
DRUGGABLE GENOMEGO terms in TNKS2
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IEA | GO:0000139 | Golgi membrane |
CC | IDA | GO:0000242 | pericentriolar material |
CC | IC | GO:0000784 | nuclear chromosome, telomeric region |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005635 | nuclear envelope |
Gene expression in normal tissue: TNKS2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TNKS2
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP3645 | NAD+ biosynthetic pathways |
reactome | R-HSA-1257604 | PIP3 activates AKT signaling |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-195721 | Signaling by WNT |
reactome | R-HSA-201681 | TCF dependent signaling in response to WNT |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in TNKS2
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |